This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures | MicrobiomeTrials
← Back to trials NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures ENROLLING_BY_INVITATION NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2005-02-23Est. Completion: 2026-06-02
Enrollment target: 3,894 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in Localized Clear Cell Renal Cell Carcinoma Resectable Clear Cell Renal Cell Carcinoma Stage II Renal Cell Cancer AJCC v8 Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8
This phase II trial studies how well ivonescimab works prior to surgery in treating patients with high-risk clear cell k…
Duarte, United States Est. completion Sep 8, 2027
Carcinoma, Neuroendocrine Tumor, Neuroendocrine Tumors, Neuroendocrine
Neuroendocrine; Carcinoma
Small Cell; Receptors
Background:
High-grade neuroendocrine carcinomas (HGNEC) are cancers that develop in different parts of the body, inclu…
Bethesda, United States Est. completion Jul 30, 2027
Hepatocellular Carcinoma (HCC) Cirrhosis Risk Prediction for Liver Cancer Epigenomics
This study aims to evaluate the role of the circulating epigenetic biomarker mSEPT9 in predicting the risk of hepatocell…
Vandœuvre-lès-Nancy, France Est. completion Jun 3, 2033